GloPID-R work in latest IPPS Report

The International Pandemic Preparedness Secretariat (IPPS) launched their fourth implementation report on January 31, 2025. The report was unveiled during an in-person event co-convened with the South African Department of Health and the South African Medical Research Council (SAMRC) in Cape Town. Read more.

GloPID-R attends ESSENCE

In February, GloPID-R attended and presented the Annual ESSENCE Meeting in Rockville, Maryland. Read more.

Our Statement

Amid ongoing outbreaks, GloPID-R remains committed to strengthening preparedness efforts. In line with this, we have released a statement reaffirming our dedication to transparency and trust in outbreak research:

At GloPID-R, we are committed to fostering an environment built on transparency, trust, and integrity. In the face of global health threats, open dialogue and information sharing are essential to ensure that critical insights are communicated rapidly and responsibly. Read more.

Pandemic PACT: Impact Survey Request, Outbreak Pages Updates and Video Release

To mark the one year anniversary of Pandemic PACT, they have published Pandemic PACT: Year One in Review. Read the full article here.

Pandemic PACT Impact Survey Request

We’re reaching out to ask if you would kindly fill out the Pandemic PACT impact survey. As you are a key stakeholder for Pandemic PACT, your feedback will help us to make continual improvements to the Pandemic PACT programme and web platform as well as guide future directions. Examples of the programme’s impact will also be crucial in demonstrating the value of Pandemic PACT to our stakeholders.

Read more updates from Pandemic PACT.

IDRCStrengthening vaccine research, ground-breaking vaccine trial and recognition for infectious disease research

Strengthening Africa’s vaccine research ecosystem

As African countries and development partners ramp up efforts to increase the continent’s vaccine manufacturing capacity, Africa’s vaccine research ecosystem must be strengthened. During the 2013 Ebola outbreak in West Africa, IDRC and international partners supported research to test a new vaccine in Guinea. This vaccine is now the cornerstone of preventing Ebola outbreaks in Africa and beyond. Without known treatments or vaccines for an infectious disease, integrating vaccine research into the response to an outbreak right from the beginning could help save millions of lives. This is why IDRC and Canadian partners are supporting the World Health Organization to strengthen research readiness for future outbreaks in 17 African countries. IDRC is partnering with the Swedish International Development Cooperation Agency on a new project to complement basic vaccine research by strengthening capacity for vaccine-related social science research. Read more.

EDCTP3 EDCTP Prizes, MoU for Public Health in Africa and Funding Research for mpox vaccine

Launch of EDCTP Prizes

In an effort to recognize outstanding individuals and research teams from Africa and Europe who have made significant achievements in their research field, Global Health EDCTP3 has launched prizes. Applicants can submit individual or team applications for the prizes, with supporting letter(s) of recommendation from at least one reputable scientist. The contest submission period will run from March 11 to April 1, 2025, at 17:00 CET, with outcomes expected to be communicated in April 2025. Read more.

WellcomeAdvancing Zika Virus Research: Key Priorities for Preparedness and Response

In 2023, Wellcome funded the Center for Infectious Disease Research and Policy (CIDRAP) at the University of Minnesota to identify key research priorities for Zika virus preparedness and response. In collaboration with global health experts, this work has now been published as a joint series in The Lancet Infectious Diseases and The Lance Microbe. This work is crucial in shaping the global response to Zika and advancing research to mitigate future risks. Read more.

ANRS MIEScientific Facilitation, Strategic Projects, Partnerships, and More

Scientific Facilitation 

ANRS MIE has been designated by the World Health Organization (WHO) to lead a Collaborative Open Research Consortium (CORC) focused on filoviruses and will become a WHO Collaborating Center. CORCs are international networks of research institutions established by WHO, each dedicated to a specific family of pathogens with pandemic potential. Their main goal is to enhance global pandemic preparedness through collaborative research by identifying key research priorities, promoting knowledge sharing, and accelerating the development of countermeasures against emerging threats. 

 Strategic Projects 

ANRS MIE is involved in the CSA CoMeCT (Coordination Mechanism for Cohorts and Trials), which aims to coordinate clinical research efforts at the European level. Specifically, ANRS MIE co-leads the Outbreak Response Board (ORB), which is responsible for developing decision-making frameworks for clinical research responses to infectious disease outbreaks and providing scientific assessments of research needs. Over the past six months, ORB has worked with the European Commission to identify clinical research priorities for Mpox (following the August 2024 Public Health Emergency of International Concern) and H5N1 (in response to the rapid spread of avian influenza in the U.S.). Read more.

UKRIUK Research and Innovation

UK Research & Innovation (UKRI), in partnership with the UK’s Department for Environment, Food and Rural Affairs and the Foreign, Commonwealth and Development Office, has just launched a new funding opportunity ‘Interdisciplinary research to tackle epidemic threats – UKRI’. The opportunity aims to better understand, predict and prevent (re-)emergence of infectious animal, human or plant diseases of epidemic potential through support of ambitious interdisciplinary research that crosses the disciplinary remits of the seven constituent Research Councils of UKRI. The opportunity will invest a minimum of £20m over five years. The conducting of such research will enhance our capability to respond to epidemic threats, through stimulating interdisciplinary research capacity and expertise. Project leads must be based at a UK research organisation eligible for UK Research and Innovation (UKRI) funding, and can include project co-leads (international). The deadline for applications is 19 June, 4pm UK time.